Form 4: Sanara MedTech CFO Elizabeth Taylor Receives Restricted Stock Grant
SEC Form 4 Filing
Elizabeth Taylor, CFO of Sanara MedTech Inc., reports the acquisition of 5,382 shares of restricted stock granted under the company's 2024 Omnibus Long-Term Incentive Plan.
Summary
- Elizabeth Taylor, the Chief Financial Officer of Sanara MedTech Inc., filed a Form 4 on February 27, 2025.
- The form reports a transaction that occurred on February 25, 2025, where Ms. Taylor acquired 5,382 shares of Sanara MedTech Inc. common stock.
- These shares were granted as restricted stock under the company's 2024 Omnibus Long-Term Incentive Plan.
- The restricted stock will vest in three equal installments: one-third on February 25, 2026, another third on February 25, 2027, and the final third on February 25, 2028.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.
Positives
- The grant of restricted stock aligns the CFO's interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the CFO over the next three years.
Future Outlook
The vesting schedule of the restricted stock suggests an expectation of continued employment and contribution from the CFO over the next three years.
Industry Context
Stock grants are a common form of executive compensation in the MedTech industry, used to incentivize performance and retain key personnel.
Comparison to Industry Standards
- Stock grants are a typical component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like MedTech.
- Companies like Stryker, Medtronic, and Boston Scientific also utilize stock-based compensation to align executive interests with shareholder value.
- The size of the grant relative to the company's market capitalization and the executive's overall compensation package would be needed for a more detailed comparison.
Stakeholder Impact
- Shareholders may view the stock grant positively as it aligns the CFO's interests with the company's long-term success.
- Employees may see this as a sign of stability and investment in leadership.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of transaction: Elizabeth Taylor acquired 5,382 shares of restricted stock. |
| 02/25/2026 | First vesting date: One-third of the restricted stock vests. |
| 02/25/2027 | Second vesting date: One-third of the restricted stock vests. |
| 02/25/2028 | Final vesting date: Remaining one-third of the restricted stock vests. |
| 02/27/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.